|
Bad Homburg, Germany - July 30, 2003 -- We are writing to ask for your cooperation and assistance in our ongoing efforts to better distinguish and differentiate our Company from FMC Corporation, a specialty chemicals manufacturing company headquartered in Chicago, Illinois. FMC Corporation stock is traded on the NYSE under the "FMC" symbol.
We have recently observed that some analysts have (understandably) employed the natural "FMC" abbreviation of our full corporate name when referring to Fresenius Medical Care AG in investment reports and other public communications.
To avoid the potential for any confusion between Fresenius Medical Care and FMC Corporation, we request that you and your colleagues refrain from future use of the FMC acronym in your reports and other communications pertaining to Fresenius Medical Care.
Optimally, you could simply use our full corporate name in any public communications. However, we appreciate that this may not always be appropriate or convenient for you. Thus, if an abbreviation is necessary, please use either our NYSE stock symbol "FMS" or our Frankfurt Stock Exchange symbol "FME" as an alternative to "FMC."
Thank you very much for your attention to this issue.
Fresenius Medical Care AG is the world's largest, integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,200,000 individuals worldwide. Through its network of approximately 1,500 dialysis clinics in North America, Europe, Latin America and Asia-Pacific, Fresenius Medical Care provides Dialysis Treatment to approximately 114,300 patients around the globe. Fresenius Medical Care is also the world's leading provider of Dialysis Products such as hemodialysis machines, dialyzers and related disposable products. For more information about Fresenius Medical Care, visit the Company's website website at http://www.fmc-ag.com.
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG does not undertake any responsibility to update the forward-looking statements in this release. |
